AEP
48
5
XOM
42
2
CPB
30
5
CME
56
3
BBY
45
3
AAP
30
3
BDX
41
3
VMC
62
5
FRT
41
5
AMAT
46
6
OKE
68
4
RIG
58
3
PYPL
41
2
BRK.B
27
2
TROW
54
6
HRB
56
2
AIV
51
4
PGR
58
6
AON
49
2
AZO
50
2
AEP
48
5
XOM
42
2
CPB
30
5
CME
56
3
BBY
45
3
AAP
30
3
BDX
41
3
VMC
62
5
FRT
41
5
AMAT
46
6
OKE
68
4
RIG
58
3
PYPL
41
2
BRK.B
27
2
TROW
54
6
HRB
56
2
AIV
51
4
PGR
58
6
AON
49
2
AZO
50
2
Financhill
Back

Genmab AS Stock Predictions

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
29

GMAB
Genmab AS

Last Price:
22.76
Seasonality Move:
4.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Genmab AS Stock Forecast

  • Over the next 52 weeks, Genmab AS has on average historically risen by 18.7% based on the past 12 years of stock performance.
  • Genmab AS has risen higher in 6 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Genmab AS Stock Undervalued?
    The current Genmab AS [GMAB] share price is $22.75. The Score for GMAB is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Genmab AS Stock Go Up Next Year?

  • Over the next 52 weeks, Genmab AS has on average historically risen by 18.7% based on the past 12 years of stock performance.

Genmab AS Stock Rating

Sell
29
Genmab AS (GMAB) is a Sell

Is Genmab AS overpriced?

  • Genmab AS has risen higher in 6 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Genmab AS Stock Price History

Is GMAB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com

52-Week Data

52-Week High:
32.89
52-Week Low:
22.18

Prediction Charts

Market Cap:
14.45B
Price in USD:
22.75
Volume:
1.64M
Beta:
0.71

Technical Analysis

SMA50:
24.68
SMA100:
25.70
SMA200:
27.29
52-Wk Change:
-21.79%

Stock Predictions

  • Is Genmab AS stock public?
    Yes, Genmab AS is a publicly traded company.
  • What is the Genmab AS stock quote today?
    The Genmab AS stock price is 22.75 USD today.
  • How to buy Genmab AS stock online?
    You can buy Genmab AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-17 22.95 22.96 22.99 22.78
Oct-18 22.78 22.98 23.09 22.73
Oct-21 22.76 22.78 22.80 22.54
Oct-22 22.43 22.77 22.79 22.39
Oct-23 22.84 22.73 22.98 22.67
Oct-24 22.82 22.82 22.98 22.78
Oct-25 22.74 23.12 23.30 22.73
Oct-28 23.08 23.14 23.21 22.95
Oct-29 23.05 23.12 23.15 22.87
Oct-30 22.69 22.57 22.82 22.56
Oct-31 22.36 22.32 22.40 22.22
Nov-1 22.61 22.56 22.63 22.53
Nov-4 22.69 22.78 22.89 22.65
Nov-5 22.56 22.75 22.84 22.18

Genmab AS Earnings

Genmab AS Earnings Report: Per Share Genmab AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Genmab AS Forecast Revenue Growth

Genmab AS Stock Analysis: Historical quarterly revenues per share for Genmab AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.33 per share.

* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.